CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-05). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2259 · Search date 2026-08-05 · Methodology v0.6

Front-pocket mobile phone carrying,
does it really help with Lower fecundability and worse semen parameters?

30-Second Summary
D
Evidence Grade D · 26 · Safety unknown
Front-pocket carrying was not consistently associated with overall fecundability or semen, but exposure measurement was crude
These data do not measure true radiofrequency or thermal exposure well enough to establish reproductive safety. Increasing distance is a low-cost option for concerned users, but shielding-product efficacy requires separate testing.
What the
research shows
The grade is D. In prospective preconception cohorts of 751 Danish and 2,349 North American men, 3,100 total, the pooled fecundability ratio for any front-pocket carrying was 0.94, 95% CI 0.83-1.05, and was not significant. The interval still permits 17% lower cycle-specific fecundability, while self-reported carrying location poorly measures radiofrequency, heat, and output, so neither harm nor safety is established.
What the
ads claim
The study did not measure phone SAR, transmitted power, or testicular temperature. It therefore supplies neither a physical exposure value nor evidence that a particular shielding product works.
*

Useful facts when choosing a product

  • Pocket location and carrying time were asked once at baseline.
  • SAR, transmitted power, model, cover, base-station distance, testicular temperature, and carrying logs were not measured.
  • Natural conception is an event; semen volume, concentration, and motility are surrogate laboratory measures.
Gap Measurement · Verdict 2259 · D 26
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Female partners reported pregnancy every eight weeks for up to 12 months. Fecundability models adjusted for male and female age and BMI, race, education, income, male activity, smoking, sleep, work hours, sexually transmitted infection history, sugary drinks, and intercourse frequency. Occupation type and true radiofrequency exposure remained potential confounders. Semen analyses used 341 North American men at first sample and 95 Danish samples, including repeat samples for some participants. Funding was NIH R03HD090315. Sandstone Diagnostics provided semen-testing kits, Swiss Precision Diagnostics provided home pregnancy tests, and Kindara and FertilityFriend provided fertility-app access in kind. L.A.W. advised AbbVie on uterine fibroids. M.L.E. advised Sandstone Diagnostics, Ro, Dadi, Hannah, and Underdog. G.J.S. held equity in Sandstone Diagnostics and disclosed a pending patent related to the Trak Male Fertility Testing System.

02

Why this is classified as D (26)

Overall fecundability and semen outcomes were null in 3,100 men, but exposure misclassification, residual occupational confounding, and a wide interval give D with 26 points rather than F.

Counterpoint. A null result does not prove front-pocket carrying is safe. Independent cohorts with objective exposure measurement or a randomized carrying intervention are needed.

Rejudgment record. Cross-check applied — Verified overall fecundability and semen tables, separated the subgroup, and incorporated self-reported exposure, residual occupational confounding, and a confidence interval that leaves harm possible

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower overall fecundabilityDFR 0.94 (0.83-1.05) was null.
Worse semen volume, concentration, and motilityDNo consistent associations were observed.
Lower fecundability among men with BMI below 25CFR was 0.72, but this was a subgroup without a duration trend.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Two prospective preconception cohorts3,100NIH R03HD090315; in-kind support from Sandstone Diagnostics, Swiss Precision Diagnostics, Kindara, and FertilityFriend; AbbVie and other company consulting, Sandstone Diagnostics equity, and a Trak patent relationship disclosedNatural conception over up to 12 months and semen volume, concentration, and motilityOverall front-pocket FR 0.94 (0.83-1.05); no consistent semen associationsDirect prospective evidence with self-reported exposure
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-05).

Hatch EE, Willis SK, Wesselink AK, et al. Hum Reprod. 2021;36(5):1395-1404. PMID: 33564831. DOI: 10.1093/humrep/deab001.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-05 · Corrections: none

Cite this verdict

Front-pocket mobile phone carrying x fecundability and semen Evidence Grade D card
[Chamgap] Front-pocket mobile phone carrying x fecundability and semen — Evidence Grade D·26. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/mens/front-pocket-cell-phone-fecundability-semen/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.